Hormone Therapy for Menopause

Systemic hormone therapy is the most effective treatment for menopause-related hot flashes and night sweats. It can also relieve vaginal symptoms and prevent bone loss while used. If nighttime heat repeatedly wakes you, controlling it may help sleep. Persistent insomnia or other symptoms can still need separate care.

Vaginal dryness, burning, and pain with sex may be treated locally when those are the main concerns. A low-dose vaginal estrogen product exposes the whole body to much less estrogen than systemic treatment. Some women need local treatment even while taking systemic HRT.

HRT is not prescribed to prevent dementia, prevent cardiovascular disease, or produce weight loss. Fatigue, anxiety, or brain fog should be assessed in context, including sleep, mood, other medicines, and possible physical causes.

The exact product matters. Vaginal delivery alone does not guarantee a local dose: some estrogen rings deliver systemic treatment. Ask the clinician or pharmacist to explain which product you have and whether uterine protection is required.

Estrogen can stimulate the lining of the uterus, called the endometrium. Systemic estrogen used without adequate protection increases endometrial cancer risk. A progestogen helps protect that lining. Progesterone is one type of progestogen; others are synthetic medicines with similar actions on the lining.

After a total hysterectomy, estrogen alone is generally appropriate if systemic therapy is chosen. If you are unsure what was removed during previous surgery, the clinician can check the operation record before choosing a regimen.

Combined treatment may use progestogen every day or during part of each month. A cyclic regimen commonly produces a scheduled withdrawal bleed. A continuous regimen aims to avoid scheduled bleeding. The choice depends on menstrual stage, formulation, and clinical history.

• Your age, menstrual history, symptoms, and the effect on daily life.
• Whether you have a uterus, previous pelvic surgery, and any unexplained vaginal bleeding.
• Personal or family cancer history, blood clots, stroke, heart disease, liver disease, and current medicines.
• Pregnancy possibility, contraception, and any previous experience with hormone treatment.

For otherwise healthy women with bothersome symptoms who are younger than 60 or within 10 years of menopause, the benefit-risk balance is generally favorable when there are no contraindications. Starting later requires more careful assessment because the absolute risks of some cardiovascular and clotting events are higher.

ACOG advises that systemic therapy is usually not recommended after breast or endometrial cancer, stroke, heart attack, blood clots, or with liver disease. Complex histories require specialist input. A family history alone also needs interpretation, with the exact diagnosis and your own risk factors considered.

Tablets, patches, gels, and sprays have different daily routines. Patches are changed on the product's schedule; tablets are taken according to the prescribed regimen. Oral estrogen has a higher clot risk than transdermal estrogen, which is delivered through the skin. A patch can also cause local irritation or problems with adhesion.

Ask for a written plan naming the estrogen, progestogen if needed, dose, application or tablet schedule, and what to do after a missed dose. Do not leave out the progestogen because the estrogen is supplied separately.

'Bioidentical' refers to hormones with the same chemical structure as those made in the body. FDA-approved estradiol and progesterone products are available. Compounded hormone preparations do not have evidence of superior safety or effectiveness and are not the routine first choice recommended by ACOG.

NICE recommends a review at three months, then annually, with earlier contact for poor response or side effects. Record the symptoms that prompted treatment so you can assess actual improvement. Breast tenderness, headaches, bloating, or mood changes may require a dose or regimen review.

Unscheduled bleeding needs clear instructions. It can occur early in systemic treatment, but persistent bleeding beyond the expected adjustment period requires assessment. Heavy bleeding, bleeding with significant pain, or bleeding that causes dizziness deserves earlier medical help.

There is no single duration that suits everyone. Continued treatment should have a clear benefit and periodic reassessment of changing health risks. If HRT is unsuitable or unwanted, nonhormonal prescriptions, vaginal moisturizers, and symptom-specific psychological treatments may provide alternatives.